Evidence map›Paper›PMID 32466166›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Effect of

Keith Wawrzeniak, Gauri Gaur, Eva Sapi, Alireza G Senejani

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Evaluating Outer Membrane Vesicle Isolation Techniques forAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Borrelia surface proteins: new horizons in Lyme disease diagnosis.Applied microbiology and biotechnology · 2025
    Review
  5. Review
  6. Heliyon · 2024
    Article
  7. Article
  8. Modulation of Macrophage Redox and Apoptotic Processes toPathogens (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Identification of microRNAs in the Lyme Disease VectorInternational journal of molecular sciences · 2022
    Article
  13. Redox Imbalance and Its Metabolic Consequences in Tick-Borne Diseases.Frontiers in cellular and infection microbiology · 2022
    Review
  14. Review
  15. Article
  16. Effect of Invasion ofAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Toxins · 2021
    Article
  19. Article
  20. Role of Outer Membrane Vesicles FromFrontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Keith WawrzeniakDepartment of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA.
Gauri GaurDepartment of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA.
Eva SapiDepartment of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA.
Alireza G SenejaniDepartment of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA.
University of New Haven · US

Funding

Leica TCS SP8 FSU AOBS 405 UV Spectral Confocal MicroscopeS10OD016435 · OD · UNIVERSITY OF CONNECTICUT STORRS · PI NISHIYAMA, AKIKO · 2014 to 2014
$456k
NIH HHS S10 OD016435
6 · The paper itself

Abstract

Outer membrane vesicles (OMVs) are spherical bodies containing proteins and nucleic acids that are released by Gram-negative bacteria, including

Indexed as

outer membrane vesicles (OMVs)reactive oxygen species (ROS)superoxide dismutase 2 (SOD2)

Identifiers

PMID32466166
PMCPMC7277464
OpenAlexW3026444693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.